| Re: question
Acid Reflux easily mimics asthma, but if it's reflux, you basically won't respond to the asthma medications.
The type of reflux that causes asthma-like symptoms is called LPR, short for Laryngopharyngeal Reflux. As the name implies, the acid is rising further up the esophogous that with regular reflux, and is actually irritating your pharynx, larynx and throat.
LPR requires more aggressive treatment that it's better known counterpart, Heartburn, which strikes the lower esophogous.
While Heartburn requires one daily dose of a PPI (proton-pump inhibitor) to clear it up, LPR requires 2 daily doses of a PPI to control it. LPR typically must be treateed with a PPI indefinitely, as it's typically a permanent condition. Luckily, most LPR patients respond to 2x daily dosing treatment very well.
The first thing you need is a prescription PPI. (DO NOT TRY PRILOSEC OTC - it doesn't work for LPR at all).
You will need the highest doses of medication in each inidividual pill. For instance, while NExium comes in the 20mg and 40 mg size pill, you will need 2 40 mg pills.
Your prescription choices are:
Nexium
Prevacid
Aciphex
Prilosec (BRAND, not OTC)
Protonix (but I wouldn't recommend it)
The reason LPR mimics asthma is basic engineering. If the acid is rising so high in the esophogous that it gets to the larynx, and the larynx is located next to the opening of the trachea (the windpipe), often a small amount of acid gets aspirated back down the trachea and gets into the lungs. The lungs have no protection against the acid, and it causes irritation, then you get asthma symptoms.
I no longer have symptoms and have been on the dual dose therapy for 4 years.
You can ask your PCP to prescribe this for you. There is plenty of information at pubmed that supports the dual dose therapy if your doctor argues with you.
[url]http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=A bstract&list_uids=12671413&query_hl=9&it ool=pubmed_docsum[/url]
There are plenty more articles there if you wish to browse it.
|